0001658021-17-000001.txt : 20170905 0001658021-17-000001.hdr.sgml : 20170904 20170905154925 ACCESSION NUMBER: 0001658021-17-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170905 DATE AS OF CHANGE: 20170905 EFFECTIVENESS DATE: 20170905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: General Oncology, Inc. CENTRAL INDEX KEY: 0001658021 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-251275 FILM NUMBER: 171068663 BUSINESS ADDRESS: STREET 1: 9 BRANDEIS ROAD CITY: NEWTON STATE: MA ZIP: 02459 BUSINESS PHONE: 617-848-0924 MAIL ADDRESS: STREET 1: 9 BRANDEIS ROAD CITY: NEWTON STATE: MA ZIP: 02459 D/A 1 primary_doc.xml X0708 D/A LIVE 0001658021 General Oncology, Inc. 9 BRANDEIS ROAD NEWTON MA MASSACHUSETTS 02459 617-848-0924 DELAWARE None None Corporation true 2015 Gregg Goldstein c/o General Oncology, Inc. 9 Brandeis Road Newton MA MASSACHUSETTS 02459 Executive Officer Director Arnold Glazier c/o General Oncology, Inc. 9 Brandeis Road Newton MA MASSACHUSETTS 02459 Executive Officer Director Henry Esber c/o General Oncology, Inc. 9 Brandeis Road Newton MA MASSACHUSETTS 02459 Director Biotechnology Decline to Disclose 06b true 0001658021-15-000001 2015-11-02 true true true A portion of the securities being offered is in connection with certain business combination transactions. 0 46905641 34803641 12102000 false 140 0 0 0 false General Oncology, Inc. /s/ Gregg Goldstein Gregg Goldstein President 2017-09-05